Prevalence, causes, and clinical associations of anemia in patients with systemic sclerosis: A cohort study

被引:0
|
作者
Gachet, Benoit [1 ,2 ,3 ]
Jouvray, Mathieu [1 ,4 ]
Koether, Vincent [1 ,5 ,6 ]
Collet, Aurore [5 ,6 ,7 ]
Morell-Dubois, Sandrine [1 ]
Sanges, Sebastien [1 ,5 ,6 ]
Sobanski, Vincent [1 ,5 ,6 ]
Hachulla, Eric [1 ,5 ,6 ]
Launay, David [1 ,5 ,6 ,8 ]
机构
[1] CHU Lille, Dept Internal Med & Clin Immunol, Lille, France
[2] Univ Lille, CH Tourcoing,ULR 2694, Dept Biostat, METR Evaluat Technol Sante & Prat Med, Lille, France
[3] Gustave Dron Hosp, Infect Dis Unit, Tourcoing, France
[4] CH Arras, Serv Med Interne, Arras, France
[5] Univ Lille, Inst Translat Res Inflammat, U1286, INFINITE, Lille, France
[6] INSERM, Lille, France
[7] CHU Lille, Inst Immunol, Pole Biol Pathol Genet Medicale, Lille, France
[8] CHU Lille, Serv Med Interne & Immunol Clin, 1 Pl Verdun, F-59045 Lille, France
关键词
Systemic sclerosis; anemia; iron deficiency; survival; ACTIVITY CRITERIA; SCLERODERMA; CLASSIFICATION; SURVIVAL; FEATURES;
D O I
10.1177/23971983241238921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Anemia is considered a risk factor of severity in systemic sclerosis. Yet, limited data are available on the frequency and causes of anemia in systemic sclerosis. The objectives of our study were to determine the frequency and causes of anemia in systemic sclerosis, to analyze the clinical and biological characteristics of patients with anemia, and to assess the association between anemia and systemic sclerosis prognosis. Methods: We conducted a prospective single-center study from January 2017 to May 2022. Patients underwent a hemoglobin assay and a standardized etiological workup to determine the causes of anemia at the initial visit. Clinical and biological parameters were compared between patients with anemia and those with normal hemoglobin levels. We followed up patients until May 2023 and compared their survival. Results: A total of 502 systemic sclerosis patients, including 107 diffuse cutaneous systemic sclerosis, were included. At enrollment, 100 patients had anemia. The primary cause of anemia was iron deficiency (40%). Among the 32 patients with iron deficiency-associated anemia who underwent gastrointestinal exploration, 56% had digestive bleeding, with upper gastrointestinal tract involvement being the main cause (90%). Patients with anemia at enrollment had higher systemic sclerosis severity scores and more gastrointestinal symptoms compared to patients without anemia (p < 0.05). They exhibited higher systolic pulmonary artery pressure, lower anemia-corrected diffusing capacity for carbon monoxide, and lower forced vital capacity (p < 0.05). During follow-up, 65 patients (14.8%) died. After adjusting for age, systemic sclerosis subtypes, forced vital capacity, and pulmonary arterial hypertension, anemia at inclusion was associated with a higher mortality rate (hazard ratio: 1.94 (95% confidence interval: 1.39-2.48), p = 0.02). Conclusion: Our study shows a high frequency of anemia among patients with systemic sclerosis. Most anemias are due to iron deficiency, and gastrointestinal exploration can identify bleeding in the majority of the cases. In addition, our study confirms that systemic sclerosis patients with anemia have a more severe disease and a higher mortality rate.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 50 条
  • [31] Clinical and serological profile of systemic sclerosis in Tunisia: A retrospective observational study
    Ben Salah, Raida
    Frikha, Faten
    Hachicha, Hend
    Chabchoub, Imen
    Dammak, Chifa
    Snoussi, Mona
    Jallouli, Moez
    Marzouk, Sameh
    Masmoudi, Hatem
    Bahloul, Zouhir
    PRESSE MEDICALE, 2019, 48 (10): : E284 - E291
  • [32] Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis
    Sumphao-Ngern, Pichaporn
    Foocharoen, Chingching
    Boonsawat, Watchara
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Sae-Oue, Uraiwan
    Netwijitpan, Sittichai
    Nanagara, Ratanavadee
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (06) : 1255 - 1260
  • [33] Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis
    Jutiviboonsuk, Arporn
    Salang, Lingling
    Eamudomkarn, Nuntasiri
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Foocharoen, Chingching
    CLINICAL RHEUMATOLOGY, 2021, 40 (06) : 2267 - 2275
  • [34] Elevated baseline serum creatine kinase in Thai early systemic sclerosis patients is associated with high incidence of cardiopulmonary complications and poor survival: an inception cohort study
    Wangkaew, Suparaporn
    Intum, Jirapath
    Prasertwittayakij, Narawudt
    Euathrongchit, Juntima
    CLINICAL RHEUMATOLOGY, 2022, 41 (10) : 3055 - 3063
  • [35] Survival in Swedish patients with systemic sclerosis: a nationwide population-based matched cohort study
    Bairkdar, Majd
    Chen, Enoch Yi-Tung
    Dickman, Paul W.
    Hesselstrand, Roger
    Westerlind, Helga
    Holmqvist, Marie
    RHEUMATOLOGY, 2023, 62 (03) : 1170 - 1178
  • [36] Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival A Large Cohort Study of the German Network for Systemic Sclerosis
    Moinzadeh, Pia
    Bonella, Francesco
    Oberste, Max
    Weliwitage, Jithmi
    Blank, Nobert
    Riemekasten, Gabriela
    Mueller-Ladner, Ulf
    Henes, Joerg
    Siegert, Elise
    Guenther, Claudia
    Koetter, Ina
    Pfeiffer, Christiane
    Schmalzing, Marc
    Zeidler, Gabriele
    Korsten, Peter
    Susok, Laura
    Juche, Aaron
    Worm, Margitta
    Jandova, Ilona
    Ehrchen, Jan
    Sunderkoetter, Cord
    Keysser, Gernot
    Ramming, Andreas
    Schmeiser, Tim
    Kreuter, Alexander
    Lorenz, Hanns-Martin
    Hunzelmann, Nicolas
    Kreuter, Michael
    CHEST, 2024, 165 (01) : 132 - 145
  • [37] Prevalence of anti-synthetase antibodies among systemic sclerosis patients
    Garra, Wakar
    Levy, Yair
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 117 : 98 - 102
  • [38] Systemic sclerosis patients with negative antinuclear antibodies have distinctive clinical manifestations: a multicenter CRDC cohort in China
    Hui, Min
    Wang, Xianbin
    Zhou, Jiaxin
    Zhang, Liyun
    Duan, Xinwang
    Li, Mengtao
    Wang, Qian
    Zhao, Jiuliang
    Hou, Yong
    Xu, Dong
    Zeng, Xiaofeng
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (SUPPL 1): : 160 - 166
  • [39] Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature
    Iniesta Arandia, Nerea
    Espinosa, Gerard
    Guillen del Castillo, Alfredo
    Tolosa-Vilella, Carles
    Colunga-Arguelles, Dolores
    Gonzalez de Echavarri Perez de Heredia, Cristina
    Lledo, Gema M.
    Comet, Luis Saez
    Ortego-Centeno, Norberto
    Vargas Hito, Jose Antonio
    Rubio-Rivas, Manuel
    Freire, Mayka
    Rios-Blanco, Juan Jose
    Rodriguez-Carballeira, Monica
    Trapiella-Martinez, Luis
    Fonollosa-Pla, Vicent
    Simeon-Aznar, Carmen Pilar
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E180 - E188
  • [40] Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study
    Werakiat, Jakrapan
    Pussadhamma, Burabha
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Foocharoen, Chingching
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2024, 5 (02): : 107 - 116